Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$71.58 - $87.29 $92,910 - $113,302
1,298 Added 18.49%
8,317 $609 Million
Q4 2023

Jan 10, 2024

SELL
$73.27 - $83.09 $40,884 - $46,364
-558 Reduced 7.36%
7,019 $569 Million
Q3 2023

Oct 11, 2023

SELL
$73.94 - $80.67 $1,109 - $1,210
-15 Reduced 0.2%
7,577 $568 Million
Q2 2023

Jul 13, 2023

BUY
$76.01 - $86.7 $2,204 - $2,514
29 Added 0.38%
7,592 $585 Million
Q1 2023

Apr 13, 2023

BUY
$77.31 - $88.08 $2,164 - $2,466
28 Added 0.37%
7,563 $627 Million
Q4 2022

Mar 01, 2023

BUY
$62.32 - $89.47 $469,581 - $674,156
7,535 New
7,535 $647 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Lakewood Asset Management LLC Portfolio

Follow Lakewood Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakewood Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lakewood Asset Management LLC with notifications on news.